SUMMARY The haematological variables, haematinic state, and placental function of more than 2000 pregnant women, heterozygous for either a-or f3-thalassaemia genes, were examined during pregnancy. Four features emerged. Firstly, it was possible by discriminant function analysis of haematological variables to distinguish in pregnant patients between the anaemia caused by thalassaemia trait and that caused by iron deficiency. Secondly, patients with thalassaemia become significantly more anaemic in pregnancy, ,8 more than a, but this was mainly due to plasma dilution. From the data percentile curves were drawn for each type of thalassaemia which predicted the patients' expected "normal" haemoglobin throughout gestation. Thirdly, patients with a-thalassaemia had the same incidence of iron deficiency as normal pregnant patients, whereas in those with f8-thalassaemia it was four times less common. The incidence of folic acid and vitamin B12 deficiency was the same in all groups. Finally, as assessed by serum oestriol concentration, there did not appear to be any abnormality of placental function or fetal development associated with maternal thalassaemia, and, also, there seemed to be no increase in maternal or fetal morbidity in pregnancy.
Adult male or female carriers of either a-or ,B-thalassaemia trait are not usually seriously anaemic, although there is some variation between ethnic groups, sexes, and individual patients.' The anaemia usually worsens at times of clinical stress, notably infection and commonly (or always) pregnancy. Indeed, female patients may present or be diagnosed for the first time in pregnancy as cases of refractory hypochromic anaemia.
Despite thalassaemia trait being the most common maternal genetic abnormality associated with pregnancy, there is still uncertainty regarding the clinical course, complications, and management, probably because there are few well reported studies.2 For example, it is uncertain, because of plasma dilution, whether or not thalassaemia trait can be suspected in pregnancy from an examination of the haematological variables. Also there are few data regarding the pathogenesis of the increased anaemia or the need for iron and folate supplementation. Finally, and most importantly, there is no evidence as to whether or not maternal thalassaemia is associated with an increase in fetal or maternal morbidity.
To investigate these problems we studied 2326 pregnant patients heterozygous for either a-thalassaemia (90%) or for ,/-thalassaemia (10%) Accepted for publication 25 March 1985 and compared our findings with those of 7000 pregnant normal subjects. types of a-and ,B-thalassaemia genes must be operative, it is useful clinically to divide carriers into three main groups depending on their mean corpuscular haemoglobin contents, which is an index as to the type and severity of the genetic defect (Table 1) . Table 2 shows the type and proportion of thalassaemia carriers in each group.
Patients and methods

PATIENTS
Iron deficient subjects Two hundred and fourteen patients had pure iron deficiency anaemia, which was suspected on haematological grounds and confirmed by finding serum ferritin concentrations of less than 10 ng/ml. All responded to oral iron treatment, and after about eight weeks the mean corpuscular haemoglobin content had risen to more than 27 pg. The haematological variables of these patients at presentation were compared with those of patients with thalassaemia.
METHODS
The routine performance of the haematology laboratory is continuously monitored by the United Kingdom national external quality assessment scheme; in 1983 and 1984 the overall assessment index was 0 5 (good).
Haematological Fig. 2 shows the variation in the mean haemoglobin concentration during pregnancy in normal subjects and in patients with thalassaemia and Table 3 shows the mean variation of all haematological variables. Although the haemoglobin concentrations in patients with thalassaemia are considerably lower than those of normal subjects when values are expressed as a ratio of the haemoglobin concentration at less than 20 weeks' gestation, the net change is the same in all four groups. This indicates that the increased anaemia is due mainly to expansion of the plasma volume with little in the way of increased haemolysis. The finding that the absolute reticulocyte counts of normal and thalassaemic patients showed no significant variation during gestation supports this conclusion. (Table 4 ). Fig. 3 shows the haemoglobin concentrations of the four groups expressed as percentile curves. The ranges of values in each group varied considerably, but the degree of variation-that is, the limits between the 10th and 90th percentiles-is roughly of the same magnitude for each group during gestation. The value of these curves in practice is illustrated by the following case history: Fig. 3 Percentile curves ofhaemoglobin concentrations ofnormal pregnant women and pregnant patients with thalassaemia (grade I-III) during gestation. Curves were drawn from the data ofmeasured values for each group. Patients were not selected, but were receiving normal antenatal care. In practice, we found that haemoglobin values falling below the 10% percentile were usually associated with a secondary cause-for example, urinary tract infection or iron deficiency. An illustration ofthe value ofsuch normograms is depicted by the case history described in the text.
was 30 weeks' pregnant. Her haemoglobin concentration had fallen to 9-0 g/dl at the 10th percentile for her a-thalassaemia. The mean corpuscular haemoglobin content was unchanged but she admitted not taking iron. Her ferritin concentration was reduced to 3-1 ng/100 ml. She was given intramuscular iron and in six weeks the haemoglobin concentration had risen to 11 g/dl, at her original 50th percentile point.
Therefore, although anaemic, the haemoglobin was now normal for her thalassaemic state. She has since delivered a healthy baby boy without any complications.
Of interest is the pattern of haemoglobin variation during gestation associated with thalassaemia. The Thalassaemia trait and pregnancy haemoglobin concentration decreased less as the grade of thalassaemia became more severe. For example, in the 23-24 pg group the decrease at 25-26 weeks (mean change in haemoglobin concentration -0-8 0-5 g/dl) was less than that in the normal subjects (-11 + 0-99 g/dl); in the 19-22 pg group the haemoglobin value increased: (mean change +0-3 0-12 g/dl). The same change in pattern is seen in the red blood cell count (Table 3) .
HAEMATINIC STATE Table 5 shows the changes in the ferritin concentrations during pregnancy in normal subjects and patients with a-and f3-thalassaemia. At term the incidence of iron deficiency in patients with a-thalassaemia is the same as that of normal subjects, but in those with /8-thalassaemia it is four times less common, occurring in no more than 4% of patients. In some patients with thalassaemia and severe iron deficiency (serum ferritin 5 ng/ml) the discriminant function, as expected, fell into the critical area. There was no precise correlation, but if patients were over deficient there was usually a fall in the mean corpuscular haemoglobin content below 28 pg.
Serum folate concentrations at less than 20 weeks' gestation showed no difference between the normal subjects and patients with thalassaemia (a or 8) (Table 6) , and by term, although the degree of deficiency was high (11%), it was the same for each group. Similarly, there was no difference in the overall vitamin 1,2 concentrations and incidence of deficiency between normal subjects and patients with thalassaemia (Table 6 ).
PLACENTAL FUNCTION
The total plasma oestriol values of 325 patients with 815 /3-or a-thalassaemia are shown in Fig. 4 , where they are compared with our own normal nonthalassaemic range. No difference was found between the two groups. This was a retrospective study-in other words, the values were obtained from the records of patients who were subsequently shown to be thalassaemia carriers.
Discussion
We believe that this report represents the largest study of the variation of the haematological state, the haematinic requirements, and the placental function in pregnancy of patients with thalassaemia. Although the patients studied originated from the Middle East, north Africa, and Indian subcontinent, it is probably correct to assume that the clinical expression of the types of thalassaemia seen are comparable with the clinical expression of the different types of molecular a-and /8-thalassaemia seen in Mediterranean and Far Eastern people.
Several points have emerged. Firstly, it is possible to distinguish with a high degree of certainty between the hypochromia caused by a-and /3-thalassaemia and that caused by pure iron deficiency anaemia in pregnancy. Patients with thalassaemia have consistently increased red cell counts compared with iron deficient pregnant patients despite expansion of plasma volume. Although the discriminant function index is only a guide to the cause of the hypochromia, it does provide a rapid simple indicator as to the need for further investigation. Moreover, as we have not found any significant decrease in the Hb A2 concentration due to frank iron deficiency anaemia (normal subjects 2-8 g/dl + 0-05%; iron deficiency 2-75 g/dl + 0.06%), and not surprisingly, during gestation, it should be possible In all but four patients the reason for measuring the oestriol concentration was for suspected placental or fetal abnormality, not for anaemia. The data were obtained from records ofpatients with mean corpuscular haemoglobin contents of18-22 pg at the time when the oestriol was measured; the diagnosis ofthalassaemia was established subsequently.
to diagnose /3-thalassaemia conclusively and a-thalassaemia by exclusion. We have ignored the likelihood that some of the patients considered as having a-thalassaemia might have 8,3 thalassaemia, but the incidence is likely to be low and also the precise type of thalassaemia is not clinically important in this study. The increased anaemia associated with thalassaemia carriers depends on the severity of the thalassaemia, a guideline to which is the mean corpuscular haemoglobin content at presentation, but during gestation it is largely due to an increase in the plasma volume. There is no evidence for increased haemolysis. We found, however, that as the expression of the type of the thalassaemia became worse-that is, the mean corpuscular haemoglobin content decreased-the pattern of haemoglobin change was quite different and was associated with an increase in the haemoglobin concentration at around 28 weeks. This could be due to an increased production of red cells at this time or, alternatively, due to a smaller change in the plasma volume. Although the latter hypothesis is difficult to prove, it is attractive and may be determined by the control of the intravascular fluid volume department, which is influenced by the osmotic control of the total intracellular haemoglobin content.
The it is thought that f3-thalassaemia is associated more with dyserythropoiesis than a-thalassaemia, thus providing a greater stimulus for iron absorption.
Results of preliminary studies, however, in which serum a-hydroxybutyrate dehydrogenase, an index of dyserythropoiesis, has been measured in patients with a-and j8-thalassaemia with severe hypochromia (mean corpuscular haemoglobin content 19-21 pg), show no significant difference (White et al, unpublished observations) . Although it appears that patients with /8-thalassaemia are "protected" from developing iron deficiency, it does occur and it would seem sensible to supplement the 1 g of iron required for each pregnancy. It is also noteworthy that none of the f3-thalassaemia carriers were iron overloaded. Finally, the most important observation is that maternal thalassaemia, as assessed from the oestriol values, does not appear to have any effect on placental function of fetal development. Moreover, there was no increase in maternal morbidity-that is, rates of caesarian section, pre-eclampsia and so on.
In summary, the results of this study suggest that 817 maternal thalassaemia per se should not give rise to concern and patients should receive normal antenatal care with no active intervention to increase the haemoglobin concentration so long as it remains within the normal expected value for that type of thalassaemia. Once thalassaemia has been diagnosed in pregnancy, then it is assumed that genetic counselling of the parents would take place.
